In this week’s COVID-19 roundup, we discuss the EUA for a breathalyzer test, updated WHO guidelines, drug-drug interactions when treating COVID, and psychiatric disorders after breakthrough infection.
The American College of Rheumatology and the American Association of Hip and Knee Surgeons have updated their recommendations on perioperative medication use for hip and knee arthroplasties in specific...
In a recent study, researchers compared the impact of more intensive blood pressure treatment with standard treatment for stroke prevention in older adults.
The US Food and Drug Administration has approved the drug based on the results from the KEEPsAKE-1 and KEEPsAKE-2 randomized, placebo-controlled studies.
In this Q&A, Abdulrahman Alsuhibani, PharmD, discusses the results of his latest study examining the relationship between adverse events and the use of anti-obesity medications.
To determine the number and characteristics of PrEP providers in the United States, researchers analyzed data from a national pharmacy database, which included more than 90% of all prescriptions dispensed...
In a recent study, researchers examined the efficacy and safety of a new monoclonal antibody for the treatment of asthma in certain patient populations.
The double-blind, phase 3 SYNAPSE trial included 407 patients from 93 sites in 11 countries. Participants were adults with recurrent, refractory, severe, bilateral nasal polyp symptoms who, despite...
To compare the effects of INSTIs with those of NNRTIs or PIs on the development of metabolic comorbidities in patients with HIV, the researchers retrospectively studied 206 incarcerated adults with HIV who...
A research team from China investigated the efficacy and safety of controversial herbal prescriptions containing Ejiao or Velvet antler for treating uterine fibroids.
